Mindray Announces Expansion of its A Series Anesthesia Portfolio

MAHWAH, N.J., Oct. 14, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced the introduction of the A3 anesthesia system, an expansion of its A Series portfolio. This is an anesthesia delivery platform that complements Mindray's broad range of ultrasound and patient monitoring systems. The products will be premiered at the American Society of Anesthesiologists (ASA) conference in Chicago, the world's largest meeting of its kind, between October 14 and 18.

Conceived through years of experience and research, both the A3 and the A5 of the A Series portfolio combine superior performance with operating simplicity, which enable anesthesiologists to meet the rising challenges in today's complex clinical environment. The products' intuitive designs reflect practical refinements that are beneficial to their day-to-day practice. The 15-inch touch screen allows clinicians to select ventilation settings more easily so that they can spend more time on patient care.

Mindray is committed to improving interoperability by using open architecture and profiles such as Health Level Seven (HL7). To further simplify interface communication, the A Series has been verified to comply with Integrating the Healthcare Enterprise -- Patient Care Domain (IHE - PCD) profiles, which are based on the HL7 and other applicable standards.

"The A3 is a great addition to our growing portfolio of anesthesia products," stated Tom Barford, Vice President of Anesthesia Systems at Mindray North America. "Like the A5, which we introduced during the ASA conference last year, the A3 has been well received by clinicians who experienced the product during the trial period. We are very excited about showcasing the A3 to anesthesia professionals from all over the world at the upcoming conference this weekend."

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://www.mindray.com.

SOURCE Mindray Medical International Limited